Literature DB >> 20953701

Negative feedback regulation of Raf/MEK/ERK cascade after sublethal cerebral ischemia in the rat hippocampus.

Q Cao1, M Qian, X F Wang, B Wang, H W Wu, X J Zhu, Ying Wei Wang, J Guo.   

Abstract

Sublethal preconditioning ischemia protects neurons from lethal ischemia, and activation of ERK is associated with this protection. However, sublethal ischemia and reperfusion also results in rapid inactivation of ERK, which contributes to the dual-phase activation profile of ERK. In the present study, we observed sublethal ischemia-induced rapid inactivation of ERK was accompanied by phosphorylation of Raf-1 at Ser289/296/301 sites. Inhibition of calcium signaling by ketamine resulted in down-regulation of the Raf-1/ERK cascade and decreased phosphorylation of Raf-1 at Ser289/296/301. The MEK inhibitor U0126 suppressed ERK activity and phosphorylation of Raf-1 at Ser289/296/301 but not Raf-1 activation elicited by its dephosphorylation at S259 following ischemia. The PP2A inhibitor cantharidin but not Pin1 inhibitor juglone blocked Raf-1 dephosphorylation at Ser289/296/301 and ERK dephosphorylation and led to ERK sustained activation, which is associated with transcriptional up-regulation of genes related to differentiation. Furthermore, dual-phase activation of ERK did not alter the mRNA levels of genes related to proliferation or differentiation. These results indicate the initial robust activation of ERK phosphorylates Raf-1 at Ser289/296/301, resulting in Raf-1inhibition and then prompt inactivation of ERK following sublethal preconditioning ischemia. Dual-phase activation of ERK may exert its neuroprotection against lethal ischemia through blocking cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953701     DOI: 10.1007/s11064-010-0285-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation.

Authors:  Satoru Sasagawa; Yu-ichi Ozaki; Kazuhiro Fujita; Shinya Kuroda
Journal:  Nat Cell Biol       Date:  2005-03-27       Impact factor: 28.824

2.  Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance.

Authors:  Z Gu; Q Jiang; G Zhang
Journal:  Neuroreport       Date:  2001-11-16       Impact factor: 1.837

3.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

Review 4.  Regulation of MAPKs by growth factors and receptor tyrosine kinases.

Authors:  Menachem Katz; Ido Amit; Yosef Yarden
Journal:  Biochim Biophys Acta       Date:  2007-01-10

5.  Extracellular signal-regulated kinase 1/2 and protein phosphatase 2A are involved in the antiproliferative activity of conjugated linoleic acid in MCF-7 cells.

Authors:  Antonella Miglietta; Francesca Bozzo; Ludovica Gabriel; Claudia Bocca; Rosa Angela Canuto
Journal:  Br J Nutr       Date:  2006-07       Impact factor: 3.718

6.  Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.

Authors:  Jie Zhao; Hui-wen Wu; Yun-jiao Chen; He-ping Tian; Li-xin Li; Xiao Han; Jun Guo
Journal:  J Neurosci Res       Date:  2008-09       Impact factor: 4.164

Review 7.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1.

Authors:  Claire J Chalmers; Rebecca Gilley; Helen N March; Kathryn Balmanno; Simon J Cook
Journal:  Cell Signal       Date:  2006-09-15       Impact factor: 4.315

9.  Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia.

Authors:  Xiaohan Hu; Xiangyang Wu; Jiali Xu; Jin Zhou; Xiao Han; Jun Guo
Journal:  BMC Neurosci       Date:  2009-07-14       Impact factor: 3.288

10.  Ceramide from sphingomyelin hydrolysis differentially mediates mitogen-activated protein kinases (MAPKs) activation following cerebral ischemia in rat hippocampal CA1 subregion.

Authors:  Xian Sun; Chao Liu; Min Qian; Zhenghong Zhao; Jun Guo
Journal:  J Biomed Res       Date:  2010-03
View more
  6 in total

1.  Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury.

Authors:  Maria Kovalska; Libusa Kovalska; Martina Pavlikova; Maria Janickova; Katarina Mikuskova; Marian Adamkov; Peter Kaplan; Zuzana Tatarkova; Jan Lehotsky
Journal:  Neurochem Res       Date:  2012-03-20       Impact factor: 3.996

2.  An L-type calcium channel agonist, bay K8644, extends the window of intervention against ischemic neuronal injury.

Authors:  Hong-hai Hu; Shu-ji Li; Pu Wang; Hua-cheng Yan; Xiong Cao; Feng-qin Hou; Ying-ying Fang; Xin-hong Zhu; Tian-ming Gao
Journal:  Mol Neurobiol       Date:  2012-10-10       Impact factor: 5.590

3.  Protective Effects of UCF-101 on Cerebral Ischemia-Reperfusion (CIR) is Depended on the MAPK/p38/ERK Signaling Pathway.

Authors:  Danying Su; Jing Ma; Zhuobo Zhang; Ye Tian; Baozhong Shen
Journal:  Cell Mol Neurobiol       Date:  2015-10-01       Impact factor: 5.046

4.  SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.

Authors:  Norihito Murayama; Taisuke Kadoshima; Naohiro Takemoto; Shiho Kodama; Tetsuya Toba; Ryoko Ogino; Takafumi Noshita; Tetsushi Oka; Shinya Ueno; Mariko Kuroda; Yoshiari Shimmyo; Yasuhiro Morita; Teruyoshi Inoue
Journal:  ACS Chem Neurosci       Date:  2012-11-21       Impact factor: 4.418

5.  Profiling status epilepticus-induced changes in hippocampal RNA expression using high-throughput RNA sequencing.

Authors:  Katelin F Hansen; Kensuke Sakamoto; Carl Pelz; Soren Impey; Karl Obrietan
Journal:  Sci Rep       Date:  2014-11-06       Impact factor: 4.379

6.  Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling.

Authors:  Ping Liu; Xiao Yang; Changchun Hei; Yvonne Meli; Jianguo Niu; Tao Sun; P Andy Li
Journal:  Int J Biol Sci       Date:  2016-07-18       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.